Long-term follow-up for people who received MB-105
This study follows people who already received an experimental treatment called MB-105 in an earlier study. It aims to track their health over time to learn more about the treatment's long-term effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have received the treatment called MB-105 in a previous study.
- You need to sign a consent form to take part.
- You agree to let researchers use samples (like blood or tissue) from your earlier study.
- You are willing and able to follow the study's rules and schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with Parkinson's disease or multiple system atrophy (parkinsonian type) who took part in an earlier AB-1005 study. It will continue to monitor your health over time to learn more about the treatment's long-term effects.
This study is a long-term follow-up for people who have already received the investigational drug CLBR001. It aims to monitor their health over time after the treatment.
This study checks how well a previous early breast cancer treatment works over the long term and monitors safety. It may help you and future patients by providing long-term results from the original trial.
This long-term follow-up study looks at people who received mentalization-based treatment (a type of therapy) more than 10 years ago for a personality disorder. The goal is to learn how their lives have changed and what value the treatment may have had over time.
This study checks on the long-term safety and how well the body handles the GC012F treatment over time. For people who already had this treatment before, it helps doctors see if the effects last and if there are any late side effects.
This study checks how people are doing long-term after they previously received a treatment called HMI 102. It may help researchers understand long-term safety and outcomes so future patients can be better supported.
Hear when a new Any Patient Treated With MB-105 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.